Drug Shortages: FDA Wants Advanced Warning; Practitioners Want Even More
This article was originally published in The Pink Sheet Daily
Presenters at drug shortage workshop want estimates of the scope and severity of a pending supply interruption to obtain alternative therapies.
You may also be interested in...
House and Senate committee user fee bill mark-ups approaching, but drafts have differences in drug shortage, supply chain security and other proposed policy changes to reconcile.
Preventing shortages through increased communications with manufacturers could gain the upper hand in part because creating economic incentives may prove too difficult and controversial.
Draft bill being developed by Rep. John Carney, D-Del., also would create system to notify the public and other manufacturers of pending shortages.